Trent Fowler is Senior Vice President, Corporate Development at Peel Therapeutics. Since joining Peel in 2016, he has helped shape portfolio strategy and steers assets from discovery through early clinical development and partnership. Earlier in his career he held laboratory and clinical research roles.

He received a BS degree from Westmont College and an MBA from the Kellogg School of Management.

Fun Fact:
Trent has taken up woodworking with a penchant for crafting butcher blocks and coffee tables